2 COVID-19 Vaccines For Young Children Show Promise In Early Trials: Study

The Moderna COVID-19 vaccine was among two vaccines which have shown promise of being safe to use on children during early trials. The research, published in the journal Science Immunology, suggests that vaccines for young children are likely important, safe tools to curtail the pandemic.

The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say. The research, published on Tuesday in the journal Science Immunology, suggests that vaccines for young children are likely important, safe tools to curtail the pandemic. "Safe and effective vaccines for young children will help limit the spread of COVID-19 because we know children can transmit the virus to others, whether they get sick from SARS-CoV-2 infection or remain asymptomatic," said Sallie Permar from New York-Presbyterian Komansky Children's Hospital, US. "Moreover, many children have become sick and even died from the infection, with many more negatively impacted by the measures put in place to curb the spread. Thus, young children deserve protection from COVID-19," Sallie Permer said.